Literature DB >> 3994100

Pharmacokinetics and bioavailability of cefazolin in horses.

R A Sams, W W Ruoff.   

Abstract

The pharmacokinetics and bioavailability of cefazolin given (IV, IM) to horses at the dosage of 11 mg/kg were investigated. The disposition of cefazolin given by IV route was characterized by a rapid disposition phase with a half-life of 5 to 10 minutes and a subsequent slower elimination phase with a half-life of 35 to 46 minutes. The total plasma clearance of cefazolin averaged 5.51 ml/min/kg and was due mainly to renal clearance (5.39 ml/min/kg) of unchanged drug. The volume of distribution at steady-state averaged 188 ml/kg. Plasma protein binding of cefazolin at a concentration of 10 micrograms/ml averaged 8.1 +/- 1.9%. Given by the IM route, cefazolin was rapidly absorbed; the extent of bioavailability was 78.4 +/- 18.8%, and the terminal half-life ranged from 49 to 99 minutes. Thus, cefazolin was extensively absorbed, but was eliminated more slowly than after IV administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994100

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.

Authors:  Dong-Ha Lee; Biruk Tesfaye Birhanu; Eon-Bee Lee; Seung-Jin Lee; Naila Boby; Yong-Soo Park; Seung-Chun Park
Journal:  Vet Res       Date:  2020-10-15       Impact factor: 3.683

3.  Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses.

Authors:  Taisuke Kuroda; Yohei Minamijima; Hidekazu Niwa; Norihisa Tamura; Hiroshi Mita; Kentaro Fukuda; Masahiro Kaimachi; Yuto Suzuki; Yuki Enoki; Kazuaki Taguchi; Kazuaki Matsumoto; Pierre-Louis Toutain; Alain Bousquet-Melou; Yoshinori Kasashima
Journal:  Equine Vet J       Date:  2021-01-21       Impact factor: 2.888

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.